AI Isn’t a Stand-Alone Solution. Let’s Stop Treating It Like One.
Nearly every conversation about the future of clinical research in today’s climate can be solved in the same way: artificial intelligence. That’s what we tell ourselves, at least. It’s become the answer to almost every challenge we face, especially when it comes to patient recruitment.
Need to identify patients faster? AI. Improve enrollment? AI. Increase diversity? AI. The excitement is understandable, but as AI takes center stage, a new problem may be emerging. Are we talking about AI as if it’s a strategy instead of what it really is: a tool?
Tools, no matter how sophisticated, don’t solve problems on their own
AI can’t compensate for siloed healthcare systems, fragmented data, research models that simply can’t scale… If we’re expecting technology to overcome those challenges by itself, we’re setting ourselves up for disappointment. Or worse, failing the patients we serve. The organizations that will benefit most from AI won’t necessarily be the ones with the newest platforms or the biggest technology investments. They’ll be the ones that have already done the hard work of connecting research to healthcare, building trusted relationships with patients and their communities, and creating an environment where better technology can actually make a meaningful difference.
It was never just about finding patients, it’s about finding them at the right time
As healthcare data becomes more connected, we’re beginning to see a different possibility. Instead of waiting for research to begin when a protocol lands at a site, technology can help identify opportunities as patients move through the care they’re already receiving. That shifts the conversation from “Who qualifies for this study?” to “Is there a research opportunity that could benefit this patient?” It’s a subtle change in wording, but a profound change in mindset. One starts with the protocol. The other starts with the person.
If we’re only counting enrollments, we’re missing the whole point
AI can do a lot. We’ve already covered that. But can AI identify cancer during a trial screening process and refer them for critical follow-up evaluation, despite the patient screen failing for the trial? Not like our people can.
This year, Javara had a patient express interest in participating in a clinical trial. But after completing the required screening process, were ultimately not eligible to enroll. If you were looking only at recruitment metrics, the outcome would be pretty straightforward: screen failure. Except that isn’t what happened.
During the screening process, abnormal findings were identified. So, the clinical research team shared those results with the patient’s treating physician, referring them for further evaluation. The diagnosis was ultimately Uterine cancer.
The patient never enrolled in the study, but the research process completely changed the trajectory of their healthy journey. It was a powerful reminder that when research is integrated into the care patients are already receiving, the value extends well beyond enrollment numbers. AI is powering immense advancement across healthcare, and clinical research specifically, but personal connection and comprehension cannot be replaced.
Takeaway
We can’t let AI consume the future of patient recruitment, replacing people or automating every decision. Changing patient lives in this new, tech-advanced world is going to be about balancing what is AI-savvy with what is human. Artificial intelligence is powerful, but it isn’t a stand-alone solution.
By John Worden, Chief Commercial Officer at Javara
